Search

The aim of the Defining NETs project was to identify the unique needs of the NET (Neuroendocrine Tumour) patient population and to develop an online and nurse-led phone-based intervention that will improve the availability of... Read more

All testing provided by the Molecular Pathology Laboratory is accredited by the National Association of Testing Authorities (NATA) Australia. Genetic characterisation enabled by cancer genomics assists clinicians in choosing... Read more

The Advanced Prostate Cancer Consensus Conference (APCCC) is underway in Switzerland, and Peter Mac’s Professor Declan Murphy is providing his expert insights from this international forum. You can hear Prof Murphy... Read more

Research led by Peter Mac has found a new combination therapy for acute myeloid leukaemia (AML) that shows greater potency in a preclinical study than either drug used alone. AML is an aggressive type of blood cancer. When a... Read more

An image of a zebrafish brain lighting up like a ball of flames has taken out the MicroART Image of the Year as part of National Science Week 2022. An image of a zebrafish brain lighting up like a ball of flames has taken... Read more

This year Peter Mac is proud to mark 75 years of serving the Australian and global cancer community.   To celebrate, our Melbourne facilities will open to the public this July as part of the program for Open House... Read more